These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17346404)

  • 1. Cancer genetics clinics and the surgeon: a valuable role for family history screening.
    Williams GL; Gray J; Beynon J
    Ann R Coll Surg Engl; 2007 Mar; 89(2):127-9. PubMed ID: 17346404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Referrals of patients to colorectal cancer genetics services in south-east Scotland.
    Holloway S; Porteous M; Cetnarskyj R; Rush R; Appleton S; Gorman D; Campbell H
    Fam Cancer; 2005; 4(2):151-61. PubMed ID: 15951967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial colorectal cancer referral to regional genetics department--a single centre experience.
    Mak T; Speake D; Lalloo F; Hill J; Evans DG
    Fam Cancer; 2007; 6(1):81-7. PubMed ID: 17160434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current surgical practice in screening for colorectal cancer based on family history criteria.
    Scholefield JH; Johnson AG; Shorthouse AJ
    Br J Surg; 1998 Nov; 85(11):1543-6. PubMed ID: 9823921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirming a diagnosis of hereditary colorectal cancer: the impact of a Familial Bowel Cancer Registry in New Zealand.
    James P; Parry S; Arnold J; Winship I
    N Z Med J; 2006 Sep; 119(1242):U2168. PubMed ID: 16998569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients.
    Grover S; Stoffel EM; Bussone L; Tschoegl E; Syngal S
    Clin Gastroenterol Hepatol; 2004 Sep; 2(9):813-9. PubMed ID: 15354282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to guidelines for the referral of patients with colorectal cancer and abnormal tumour tissue testing for assessment of Lynch syndrome.
    Han J; Spigelman AD
    ANZ J Surg; 2019 Oct; 89(10):1281-1285. PubMed ID: 30856687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why do women not return family history forms when referred to breast cancer genetics services? A mixed-method study.
    Hanning KA; Steel M; Goudie D; McLeish L; Dunlop J; Myring J; Sullivan F; Berg J; Humphris G; Ozakinci G
    Health Expect; 2015 Oct; 18(5):1735-43. PubMed ID: 24386893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of family cancer history assessment at initial surgical consultation.
    Ruo L; Cellini C; La-Calle JP; Murray M; Thaler HT; Quan SH; Guillem JG
    Dis Colon Rectum; 2001 Jan; 44(1):98-103; discussion 103-4. PubMed ID: 11805570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics improves the management of hereditary non-polyposis colorectal cancer.
    Ramesar RS; Madden MV; Felix R; Harocopos CJ; Westbrook CA; Jones G; Cruse JP; Goldberg PA
    S Afr Med J; 2000 Jul; 90(7):709-14. PubMed ID: 10985134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preventive registry for hereditary nonpolyposis colorectal cancer.
    Madlensky L; Berk TC; Bapat BV; McLeod RS; Couture J; Baron D; Hiruki T; Redston M; Cohen Z; Gallinger S
    Can J Oncol; 1995 Jul; 5(2):355-60. PubMed ID: 8853507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of patient reports on the referral process to two NSW cancer genetic services.
    Butel-Simoes GI; Spigelman AD
    Fam Cancer; 2014 Sep; 13(3):333-43. PubMed ID: 24648127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we identify the high-risk patients to be screened? A genetic approach.
    Gammon A; Kohlmann W; Burt R
    Digestion; 2007; 76(1):7-19. PubMed ID: 17947814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening relatives of patients with colorectal cancer: the need for continuing education.
    Heriot AG; Murday V; Kumar D
    J R Coll Surg Edinb; 1999 Feb; 44(1):13-5. PubMed ID: 10079661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of database linkage: are patients at risk of familial colorectal cancer being referred for genetic counselling and testing?
    Wong C; Gibbs P; Johns J; Jones I; Faragher I; Lynch E; Macrae F; Lipton L
    Intern Med J; 2008 May; 38(5):328-33. PubMed ID: 17916174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.
    Wilson BJ; Torrance N; Mollison J; Wordsworth S; Gray JR; Haites NE; Grant A; Campbell MK; Miedyzbrodzka Z; Clarke A; Watson MS; Douglas A
    Health Technol Assess; 2005 Feb; 9(3):iii-iv, 1-126. PubMed ID: 15694064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonoscopy surveillance of individuals at risk of familial colorectal cancer.
    Bradshaw N; Holloway S; Penman I; Dunlop MG; Porteous ME
    Gut; 2003 Dec; 52(12):1748-51. PubMed ID: 14633955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology.
    Batra S; Valdimarsdottir H; McGovern M; Itzkowitz S; Brown K
    Am J Gastroenterol; 2002 Mar; 97(3):729-33. PubMed ID: 11922570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.